An endometrial biopsy involves taking a small tissue sample from the uterine lining for microscopic examination. A “benign” designation indicates the absence of cancerous or precancerous cells. This outcome typically signifies a normal or non-threatening condition, such as a regular menstrual cycle or a benign polyp. For example, a woman experiencing irregular bleeding might undergo this procedure, and a benign result would likely alleviate concerns about malignancy.
A negative for atypical or malignant cells offers significant reassurance and frequently eliminates the need for more invasive procedures. Historically, evaluating uterine health relied heavily on more extensive surgical interventions. The development and refinement of the biopsy technique has provided a less invasive and often more conclusive diagnostic tool. This has greatly improved patient care and reduced potential complications.